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 17 
Abstract  18 
Viruses are ubiquitous pathogens of global impact. Prompted by the hypothesis that their earliest 19 
progenitors recruited host proteins for virion formation, we have used stringent laboratory 20 
evolution to convert a bacterial enzyme lacking affinity for nucleic acids into an artificial 21 
nucleocapsid that efficiently packages and protects multiple copies of its own encoding mRNA. 22 
Revealing remarkable convergence on the molecular hallmarks of natural viruses, the 23 
accompanying changes reorganized the protein building blocks into an interlaced 240-subunit 24 
icosahedral capsid impermeable to nucleases, while emergence of a robust RNA stem-loop 25 
packaging cassette ensured high encapsidation yields and specificity. In addition to evincing a 26 
plausible evolutionary pathway for primordial viruses, these findings highlight practical 27 
strategies for developing non-viral carriers for diverse vaccine and delivery applications.  28 
 29 
One Sentence Summary 30 
A bacterial protein evolved to efficiently package and protect its own genome begins to resemble 31 
a natural virus. 32 




Main Text 34 
Understanding the origins and evolutionary trajectories of viruses is a fundamental scientific 35 
challenge (1). Even the simplest virions, optimized for genome propagation over billions of years 36 
of evolution, require co-assembly of many copies of a single protein with an RNA or DNA 37 
molecule to afford a closed-shell container of defined size, shape, and symmetry. Strategies for 38 
excluding competing host nucleic acids and protecting the viral genome from nucleases are also 39 
needed. While recreating such properties in non-viral containers is challenging (2–6), capsids 40 
generated by bottom-up design are promising as customizable tools for delivery and display (7–41 
9).  42 
Previous efforts to produce artificial nucleocapsids that encapsulate their own genetic 43 
information have utilized natural and computationally designed protein cages possessing 44 
engineered cationic interiors (5, 6). However, even after directed evolution only ~10% of the 45 
resulting particles contained the full-length target RNA, underscoring the difficulties associated 46 
with packaging and protecting nucleic acids in a cell. In addition to competition from abundant 47 
host nucleic acids, genome degradation by cellular RNases is problematic owing to slow 48 
assembly, cage dynamics and/or porosity. Here we show that complementary adaptations of 49 
cargo and container can be harnessed to address these challenges and recapitulate the structural 50 
and packaging properties of natural viruses. 51 
Our starting point was a previously evolved nucleocapsid, derived from Aquifex aeolicus 52 
lumazine synthase (AaLS), a bacterial enzyme that naturally forms 60-subunit nanocontainers 53 
but has no inherent affinity for nucleic acids (10). AaLS was redesigned by circular permutation 54 
and appending the arginine-rich peptide lN+, which tightly binds an RNA stem-loop called 55 
BoxB (11, 12) (Fig. S1A). The resulting nucleocapsid variant, NC-1 (previously called 56 
λcpAaLS), was subsequently evolved via intermediate NC-2 (λcpAaLS-β16) to NC-3 (λcpAaLS-57 
α9) by selecting for variants that capture capsid-encoding mRNA transcripts flanked by BoxB 58 
tags. Nevertheless, only one in eight of the NC-3 capsids packaged the full-length RNA genome 59 
(6). 60 
To improve NC-3’s packaging properties, we mutagenized its gene by error-prone PCR and 61 
subjected the library to three cycles of expression, purification, and nuclease challenge, followed 62 
by re-amplification of the surviving mRNA. Selection stringency was steadily increased in each 63 
cycle by decreasing nuclease size (60 kDa benzonase à 14 kDa RNase A à 11 kDa RNase T1) 64 
and extending nuclease exposure from 1 to 4 hours. This strategy ensured 1) efficient assembly 65 
of RNA-containing capsids, 2) protection of the cargo from nucleases, and 3) enrichment of 66 
variants that package the full-length mRNA (Fig. 1A). The best variant, NC-4, had nine new 67 
mutations, three of which were silent (Figs. S2,S3). 68 
After optimizing protein production and purification, we compared NC-4 to its precursors. 69 
Particle heterogeneity decreased notably over the course of evolution from NC-1 so that NC-4 70 
assembles into homogeneous capsids (Fig. S1B,C), with protein yields after purification that 71 




~3 mg NC-3/L). Additionally, nuclease resistance steadily improved. NC-1 RNA is almost 73 
completely degraded upon treatment with either benzonase or RNase A, whereas NC-2 protects 74 
small amounts of full-length mRNA from benzonase but not RNase A (Fig. S1D). In contrast, 75 
both NC-3 and NC-4 protect most of their encapsidated RNA from both nucleases (Fig. S1D,E). 76 
Importantly, NC-4 also packages its own full-length mRNA with improved specificity. While 77 
earlier generations encapsidate a broad size range of RNA species (400–2000 nt), NC-4 binds 78 
one major species corresponding to the 863 nt-long capsid mRNA (Fig. 1B, left). Long-read 79 
direct cDNA sequencing confirmed the decrease in encapsidated host RNA (Fig. 1C), which was 80 
largely ribosomal (Fig. S4). The simultaneous increase in genome packaging efficiency over the 81 
four generations is clearly evident in gels stained with the fluorogenic dye DFHBI-1T, which 82 
binds the Broccoli aptamers (13) introduced with the BoxB tags (6) (Fig. 1B, right). 83 
The fraction of full-length genome relative to total encapsidated RNA was quantified by real-84 
time PCR to be (2±2)% for NC-1, (6±5)% for NC-2, (24±12)% for NC-3 and (64±11)% for NC-85 
4 (Fig. 1D). When NC-4 was further purified by ion-exchange chromatography to remove 86 
incomplete or poorly-assembled capsids, (87±19)% of the RNA corresponded to the full-length 87 
genome. Given the total number of encapsidated nucleotides (~2500), NC-4 packages on average 88 
2.5 full-length mRNAs per capsid, a dramatic improvement compared to its precursors and other 89 
artificial nucleocapsids (5, 6). This packaging capacity suggests that the evolved capsid could 90 
readily accommodate substantially longer RNAs, such as more complex genomes or large RNA 91 
molecules of medical interest.  92 
Improved genome packaging and protection were accompanied by major structural 93 
transformations. The cavity of the starting 16 nm diameter AaLS scaffold is too small to package 94 
an 863 nt-long RNA (2, 6). However, addition of the lN+ peptide to circularly permuted AaLS 95 
afforded expanded capsids with diameters in the 20–30 nm range, which were subsequently 96 
evolved toward uniform ~30 nm diameter particles (Fig. S1C). To elucidate the nature of these 97 
changes, we turned to cryo-EM. 98 
Characterization of the initial NC-1 design revealed a range of assemblies of varying size and 99 
shape (Fig. S5A,B). Although particle heterogeneity and aggregation complicated single-particle 100 
reconstruction, two expanded structures with tetrahedral symmetry were successfully obtained 101 
(Fig. 2A). Like the wild-type protein, both are composed entirely of canonical lumazine synthase 102 
pentamers (Fig. 3A), but they possess large, keyhole-shaped pores (~4 nm wide) through which 103 
nucleases could diffuse. One capsid is a 180-mer (Fig. S5C–F, Table S1) that closely resembles a 104 
previously characterized AaLS variant possessing a negatively charged lumen (14, 15). The other 105 
NC-1 structure is an unprecedented 120-mer (Fig. S5G–I, Table S1). It features wild-type-like 106 
pentamer-pentamer interactions as well as inter-pentamer contacts characteristic of its 180-mer 107 
sibling (Fig. 2A). At the monomer level, the major deviation from the AaLS fold is seen in a 108 
short helix (residues 67–74) and adjacent loop (residues 75–81) (Fig. 2B,C). In AaLS, this region 109 
is involved in lumenal interactions between the pentameric building blocks at the threefold-110 




contacts, this loop assumes altered conformations and is resolved to lower local resolution (Figs. 112 
2B,C, S5E,H).  113 
The second-generation variant NC-2, obtained after benzonase challenge, is also polymorphic 114 
and aggregation-prone. Several distinct morphologies were identified by 2D-classification 115 
(Fig. S6), one of which was reconstructed as a tetrahedrally symmetric 180-mer (4.5 Å, Fig. 2A, 116 
Table S1) that superimposes on the analogous NC-1 structure. Four mutations (I58V, G61D, 117 
V62I, and I191F) shorten two strands of the core beta-sheet and, indirectly, further increase 118 
disorder in neighboring residues 66–81 (Fig. 2B,C). These changes disfavor wild type-like 119 
pentamer-pentamer interactions, explaining the absence of smaller capsids with more tightly 120 
packed capsomers (16). Structural heterogeneity and particle aggregation precluded 121 
reconstruction of additional structures that may contribute to the benzonase-resistance 122 
phenotype.  123 
The ability of NC-3 and NC-4 to protect their cargo from RNases significantly smaller than 124 
the pores in the parental structures suggests a novel solution to nuclease resistance. In fact, three-125 
dimensional reconstructions of NC-3 (7.0 Å) and NC-4 (3.0 Å) (Fig. S7, Table S1) yielded 126 
superimposable structures that are markedly different from any previously characterized AaLS 127 
derivative (Fig. 2A). Both capsids form icosahedrally symmetric 240-mers that feature smaller 128 
pores (~2.5 nm) than their progenitors. The pentagonal vertices align with AaLS pentamers, and 129 
are surrounded by 30 hexagonal patches (Figs. 3B, S8). This architecture is typical of T=4 virus 130 
capsids, in which a single protein chain assumes four similar, quasi-equivalent conformations, 131 
repeated with icosahedral symmetry to afford a closed container with increased volume (17).  132 
The most striking feature of our evolved cages is a 3D-domain swap (18), which links 133 
neighboring monomers and reorganizes the structure into trimeric building blocks (Figs. 3B, S8). 134 
As reported for some viral capsids (19–22), such interlacing may enhance particle stability. This 135 
rearrangement was made possible by a hinge around residues 62–66, which permits dissociation 136 
of the N-terminal helix and strand of each subunit from the core, allowing it to dock onto a 137 
neighboring subunit in the trimeric capsomer. An elongated alpha-helix extends C-terminally 138 
from this hinge, formed by fusing the short helix (residues 67–74) to the following helix by 139 
ordering of the intervening loop (residues 75–81) (Figs. 2C, S9A). Slight variations in the hinge 140 
angles allow the subunits to occupy four quasi-equivalent positions within the expanded 141 
icosahedral lattice (23) (Figs. 3C, S8D-G) and repurpose the inter-pentamer interfaces of the 142 
wild-type scaffold for penton-hexon contacts (Fig. S9). Such flexible hinges might similarly be 143 
exploited for the rational design of large (T>1) capsid assemblies from a single protein chain, an 144 
as yet unmet challenge due to the difficulty of designing proteins capable of adopting several 145 
distinct conformations.   146 
The smaller pores in the NC-3 and NC-4 shells provide a compelling explanation for nuclease 147 
resistance. The structurally unresolved lN+ peptides, which line the lumenal edge of these 148 
openings, likely further restrict access to the cage interior. Nevertheless, the superimposable 149 




Although a lysine to arginine mutation that appeared in the lN+ peptide of NC-4 is known to 151 
increase affinity to the BoxB tags ~3-fold (11), the effects of reverting this mutation are modest 152 
(Fig. S10), indicating that other factors must be at play.  153 
An NC-4 variant lacking the RNA-binding peptide still assembles into capsids, but the yields 154 
decrease ~2-fold and the resulting particles are heterogeneous in both size and shape (Fig. S11), 155 
suggesting a potential role for RNA in capsid formation. Some viruses that package single-156 
stranded RNA genomes utilize multiple stem-loop packaging signals to orchestrate capsid 157 
assembly and ensure cargo specificity within the crowded confines of the cell (24). Could the 158 
evolution of additional RNA packaging signals in the NC-4 genome explain its superiority to 159 
NC-3? Besides the originally introduced BoxB tags (6), BB1 and BB2, both genomes have 37 160 
BoxB-like URxRxRR (R=purine) and URxR sequences (25) (Table S2). In order to determine 161 
whether any of these serve as packaging signals, we used synchrotron X-ray footprinting (XRF). 162 
Synchrotron radiation generates hydroxyl radicals, which cleave the RNA backbone. Because 163 
base-pairing and intermolecular interactions, such as with protein, decrease local cleavage 164 
propensity, XRF provides a means to map intermolecular interactions and RNA secondary 165 
structure (26). 166 
Footprints for packaged NC-3 and NC-4 RNA show that only BB1, BB2, and 11 out of 37 167 
BoxB-like motifs exhibit low XRF reactivity (Table S2). Furthermore, XRF-informed prediction 168 
of RNA secondary structure ensembles (27, 28) indicates that only seven of these motifs (BB1, 169 
BB2, and potential packaging signals PS1–5) are presented as stem-loops with significant 170 
frequency (Figs. S12A, S13A). Assuming that interactions with the lN+ peptides stabilize the 171 
stem-loops, comparison of their display frequency in encapsulated versus free RNA pinpoints 172 
which of these motifs might serve as packaging signals.   173 
In NC-3, the secondary structure predictions (Figs. 4A,C,E, S12) indicate that the original 174 
high-affinity BoxB tags are more frequently displayed as stem-loops in free transcripts than in 175 
capsids (96% vs. 63% for BB1 and 75% vs. 52% for BB2). Although the five lower affinity 176 
PS1–5 motifs are displayed more frequently upon encapsulation, their broad distribution, 177 
coupled with modest display of the high-affinity tags, contrasts with natural viruses, which 178 
appear to utilize narrow clusters of packaging signals surrounding an efficiently displayed, high-179 
affinity stem-loop to initiate capsid assembly (24). The lack of robust assembly instructions may 180 
explain why 72% of the RNA packaged in NC-3 is ribosomal. Ribosomal RNA is compact, 181 
abundant and also possesses multiple BoxB-like signals (Fig. S4C,D), which may allow it to 182 
function as an alternative nucleation hub for capsid assembly. 183 
In NC-4, four of the seven potential packaging signals are significantly populated as stem 184 
loops in packaged genomes (PS1, BB1, PS2, PS4) and all are clustered at the 5'-end of the 185 
transcript. Notably, BB1 is displayed in 99% of all packaged RNA folds (Figs. 4B,D, S13). The 186 
low reactivities observed for the four URxR sub-motifs within the capsid (Fig. 4F) imply that 187 
they are in contact with protein. Robust display of a high-affinity packaging signal within a 188 




found in Satellite Tobacco Necrosis Virus (29), MS2 phage (30), and Hepatitis B Virus (31). 190 
This finding suggests that NC-4 similarly evolved a key hallmark of RNA packaging signal-191 
mediated assembly. Genome-encoded packaging instructions likely foster selective RNA 192 
encapsulation as well as rapid, efficient capsid assembly (32), providing a compelling 193 
explanation for the improved properties of the evolved cage (Fig. 4G). Encapsulation of 194 
alternative or longer, more complex genomes may similarly benefit from optimization of RNA 195 
sequence and structure.  196 
Successful conversion of a bacterial enzyme into a nucleocapsid that packages and protects its 197 
own encoding mRNA with high efficiency and selectivity shows how primordial self-replicators 198 
could have recruited host proteins for virion formation (1). While we started from a capsid-199 
forming enzyme, similar pathways could be envisioned for smaller oligomeric proteins, where 200 
cargo protection would provide the evolutionary driving force towards shell formation. The 201 
convergence on structural properties characteristic of natural RNA viruses through co-evolution 202 
of capsid and cargo is striking. Introduction of destabilizing mutations into the starting protein 203 
was key to the dramatic remodeling of the protein shell, providing the molecular heterogeneity 204 
needed to depart from the initial, energetically stable, architectural solution and converge on a 205 
regular, 240-subunit, closed-shell icosahedral assembly. At the same time, evolution of multiple 206 
RNA packaging motifs that can cooperatively bind the coat proteins likely guided specificity and 207 
efficient assembly. While such constructs are themselves attractive as customizable and 208 
potentially safe alternatives to natural viruses for gene delivery and vaccine applications, the 209 
lessons learned from their evolution may also inform ongoing efforts to tailor the properties of 210 
natural viruses for more effective gene therapy (33). 211 
 212 
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Fig. 1. NC-4 packages its genome with high selectivity. (A) Laboratory evolution: a library of NC-3 379 
mutants generated by error-prone PCR was expressed in Escherichia coli and purified by affinity and size 380 
exclusion chromatography. This step recovers assembled capsids. The purified capsid library was then 381 
treated with nucleases to enrich for capsids that protect their RNA cargo. Finally, the RNA was extracted 382 
from capsids, reverse-transcribed, and re-cloned into the original expression vector. This step selects for 383 
capsids that contain full-length genomes. (B) Denaturing PAGE (5%) of NC-1 to NC-4 stained for total 384 
RNA with GelRed (left) and the fluorogenic dye DFHBI-1T (right), which selectively binds the broccoli 385 
aptamer present in the 5’- and 3’-untranslated regions of the mRNA genome (NC RNA). IVT, in vitro-386 
transcribed reference mRNA. (C) RNA identities and their relative abundance were determined by 387 
Oxford Nanopore Sequencing (34) for all four capsids, including anion-exchanged NC-4 (4-AEX), and 388 
assigned to three main categories: bacterial RNA (E. coli), nucleocapsid mRNA (NC), and RNA 389 
originating from other plasmid-associated genes (plasmid). The encapsulated E. coli genes are primarily 390 
rRNA (Fig. S4). (D) The fraction of total extracted RNA corresponding to the full-length mRNA genome 391 
was determined by real-time quantitative PCR (mean of at least two biological replicates, each measured 392 





Fig. 2. Structural evolution towards virus-like nucleocapsids. (A) Maps are shown for the 395 
tetrahedrally symmetric NC-1 and NC-2 structures with symmetry-related pentamers in the same color, 396 
and the icosahedral T=4 NC-4 capsid with the four quasi-equivalent chains highlighted in different colors. 397 
The lower resolution NC-3 capsid (7.0 Å, Fig. S7) resembles NC-4. Wild-type AaLS (10) is shown for 398 
comparison (not to scale). Resolutions were estimated by Fourier shell correlation (0.143 threshold). (B) 399 
Fits of single chains (rainbow; N-terminus to C-terminus from blue to red) in the electron density of the 400 
capsids above show the evolution of the monomer. Residues 66 to 81 are highlighted (yellow). Clear 401 
density is seen for this segment in NC-1 protomers involved in AaLS-like inter-pentamer contacts. In 402 
other chains, as in the 180-mer NC-1 structure, this region is less well resolved. In NC-2 the nearby beta-403 
sheet is also perturbed, further enhancing the flexibility of this region. In NC-3 and NC-4, this segment 404 
rearranges into an extended helix that supports the domain swap. (C) Rainbow-colored models depict the 405 
changes in the protein fold. The helix (67–74) and loop (75–81) that undergo a major rearrangement are 406 
colored in pink, and the hinge loop (62–66) in yellow; the structurally unresolved RNA-binding peptide is 407 







Fig. 3. Virus-like architecture by protomer reorganization. (A) The assembly of 120- and 180-subunit 412 
NC-1 and NC-2 cages from monomers (cartoon and surface shown in grey) presumably proceeds via 413 
AaLS-like pentamers. (B) Based on the assembly mechanisms of other viral capsids (35), the T=4 capsids 414 
likely arise from domain-swapped trimeric building blocks that further combine into pentamers. 415 
Combining the latter with additional domain-swapped trimers (blue) would afford the complete 416 
240-subunit capsid. The pentagonal and hexagonal faces of the icosahedrally symmetric capsid are 417 
highlighted by a white lattice. (C) Assembly of the T=4 icosahedral NC-3 and NC-4 structures requires 418 
the subunits to adopt different, quasi-equivalent conformations. An overlay of the four quasi-equivalent 419 
chains of NC-4, colored as in panel B, shows that the hinge region provides flexibility for subtle 420 
adjustments in the relative orientation of the flanking segments. Additional differences are visible in the 421 
poorly resolved surface loop introduced by circular permutation (cp-loop), which interacts with the 422 






Fig. 4. Virus-like genome packaging mediated by packaging signals. (A,B) XRF reactivities were used 426 
to calculate how frequently the seven packaging signal candidates occur in stem-loops in the NC-3 (A) 427 
and NC-4 (B) mRNA genomes; 1000 sample folds were generated for each of 1116 combinations of 428 
reactivity offsetting and scaling factors (see Figs. S12,S13). Cumulative display frequencies of the motifs 429 
as stem-loop are plotted against genome position for the packaged transcripts (bars), with the high-affinity 430 
BoxB tags highlighted in orange, BoxB-like PS1–5 motifs in blue, and the respective in vitro-transcribed 431 
RNA indicated by black lines; arrows show the increase or decrease observed upon packaging. (C,D) 432 
Two consensus folds predicted for packaged NC-3 and NC-4 mRNA (see also Figs. S12,S13). Secondary 433 
structure features shared between the respective folds are highlighted in grey. These structures indicate 434 
more extensive fold conservation in NC-4, as well as more robust display of a packaging cassette 435 
comprising PS1, BB1, PS2, and PS4, than in NC-3. (E,F) Reactivities of the URxRxRR motifs displayed 436 
in the packaged NC-3 (E) and NC-4 (F) RNA folds depicted in panels (C) and (D), respectively. 437 
Reactivity follows the order: red (high)à yellowà greenà black (low). The four packaging signal 438 
candidates in NC-4 show low reactivities, consistent with protection by capsid protein. (G) The evolution 439 
of a packaging cassette that steers efficient capsid assembly around the target RNA provides a compelling 440 
explanation for the improved properties of NC-4 compared to NC-3. 441 
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Materials and Methods 464 
The nomenclature for the previously published nucleocapsids (6) was simplified to make the 465 
evolutionary relationship between the different variants clearer. NC-1 corresponds to λcpAaLS, 466 
the original nucleocapsid generated by circular permutation of AaLS and addition of the 467 
λN+ peptide to the new lumenal N-terminus; NC-2 is the best variant obtained after one round of 468 
optimization, λcpAaLS-β16; and NC-3 is the best performing variant from the second 469 
evolutionary round, λcpAaLS-α9 (6). The final variant, NC-4, was evolved in the current study. 470 
 471 
Library construction by error-prone PCR 472 
Error-prone PCR was carried out using the JBS Error-Prone Kit (#PP-102, Jena Bioscience) 473 
according to the manufacturer’s protocol. Two primers (primer 1: 5’- GCG GAT AAC AAT 474 
TCC CCT CTA GAG; primer 2: 5’- GGG TTA TGC TAG TTA TTG CTC AGC G) were used 475 
with pMG-dB-λcpAaLS-α9 (6) as a template. PCR products were purified using the Zymoclean 476 
Gel DNA Recovery Kit (#D4001, Zymo Research). Both the products and the acceptor vector 477 
(pMG-dB) were doubly digested at their NdeI and XhoI restriction sites. The DNA fragments 478 
were purified using the DNA Clean & Concentrator-5 (#D4013, Zymo Research), ligated with 479 
T4 DNA ligase (#M0202, NEB), and purified again using the same kit. The capsid library (~1 μg 480 
ligation product) was transformed into electrocompetent Escherichia coli XL1-Blue cells by 481 
electroporation. The cells were incubated in 50 mL Luria-Bertani (LB) medium for 1 hour at 482 
37 °C. The library size (~3 x 106 mutants) was determined by plating serial dilutions of the cell 483 
suspension onto LB-agar plates containing ampicillin (50 μg/mL). To the remaining cells, LB 484 
medium and ampicillin (50 μg/mL) were added to the original volume of 50 mL. Cells were 485 
cultured overnight at 37 °C and 230 rpm. The next day, plasmid DNA was extracted using the 486 
ZR Plasmid Miniprep Classic Kit (#D4016, Zymo Research). 487 
 488 
Directed evolution of NC-4 from NC-3 489 
Evolution of NC-4 was based on a plasmid library generated by error-prone PCR as described 490 
above. The library was subjected to three iterative cycles of selection. Each cycle involved 491 
transformation of E. coli cells, expression of the nucleocapsid variants, isolation, and purification 492 
by affinity and size, nuclease treatment, RNA extraction, reverse transcription, and re-ligation of 493 
the surviving variants into the vector backbone. Nuclease selection stringency was increased in 494 
each cycle. 495 
Initially, electrocompetent E. coli BL21(DE3)-gold cells were transformed with the plasmid 496 
library and incubated in 4 mL LB medium for 1 hour at 37 °C. After adding ampicillin 497 
(50 μg/mL), cells were cultured at 37 °C and 230 rpm for an additional 6 hours. This 4-mL 498 
culture was then transferred to 400 mL LB medium containing ampicillin (50 μg/mL) and 499 
cultured as before until the OD600 reached 0.4–0.6, at which point protein production was 500 
induced by adding isopropyl ß-D-1-thiogalactopyranoside (IPTG) to a final concentration of 501 
0.2 mM. Cells were cultured at 20 °C and 230 rpm for 16 hours, then harvested by centrifugation 502 
at 5,000 g and 4 °C for 10 min. The pellet was stored at -20 °C until purification. For 503 
purification, cells were resuspended in 15 mL lysis buffer (50 mM sodium phosphate buffer, pH 504 
7.4) containing 1 M NaCl and 20 mM imidazole supplemented with lysozyme (1 mg/mL; 505 
#A3711, AppliChem) and DNase I (10 μg/mL; #A3778, AppliChem). The mixture was 506 
incubated at room temperature for 1 hour. After lysis by sonication and clearance by 507 
centrifugation at 9,500 g and 25 °C for 25 min, the supernatant was loaded onto 2 mL of 508 




buffer containing 1 M NaCl and 20 mM imidazole, and protein was eluted with lysis buffer 510 
containing 200 mM NaCl and 500 mM imidazole. The buffer was exchanged to 50 mM sodium 511 
phosphate buffer (pH 7.4), 5 mM EDTA (storage buffer) containing 200 mM NaCl, using an 512 
Amicon Ultra-15 centrifugal filter unit (30 kDa MWCO, Merck Millipore). Capsids were further 513 
purified by size-exclusion chromatography (SEC) on a Superose 6 increase 10/300 GL (GE 514 
Healthcare) in storage buffer with 200 mM NaCl. Proteins were purified at room temperature.  515 
For the selection of capsids that protect their RNA genome from nucleases, a solution of 516 
capsids containing approximately 2 μg of total RNA was treated at 37 °C for 1 hour with 517 
benzonase (2.5 U/μL; #101654, Merck Millipore) in 250 μL of storage buffer supplemented with 518 
5 mM MgCl2. RNA was then extracted with TRIzol reagent (#15596026, Invitrogen) and 519 
dissolved in water. The resulting RNA sample was incubated with RQ1 DNase (#M6101, 520 
Promega) in the manufacturer’s reaction buffer at 37 °C for 1 hour and subsequently purified by 521 
phenol-chloroform extraction and ethanol precipitation. From this RNA, complementary DNA 522 
(cDNA) was prepared by reverse transcription with primer 3 (primer 3: 5’- GCG GAT AAC 523 
AAT TCC CCT CTA GAG) using SuperScript III reverse transcriptase (#18080044, Invitrogen) 524 
according to the manufacturer’s protocol. The resulting cDNA was amplified in 30 PCR cycles 525 
with Phusion High-Fidelity DNA polymerase (#M0530, NEB) using primers 3 and 4 (primer 4: 526 
5’- GGG TTA TGC TAG TTA TTG CTC AGC G). Purified DNA was digested with NdeI and 527 
XhoI restriction enzymes and ligated into the pMG-dB acceptor vector.  528 
The resulting plasmid library was then employed in the next cycle, carried out as above, but in 529 
the presence of RNase A (10 μg/mL; #R4875, Sigma-Aldrich) instead of benzonase. The 530 
surviving variants were then subjected to a third cycle, with two modifications of the selection 531 
protocol. First, gel filtration was carried out on a HiPrep 16/60 Sephacryl-S400 (GE Healthcare) 532 
column, which has poorer resolution than the previously used column, but its higher exclusion 533 
volume allows efficient removal of larger aggregates. Second, nuclease treatment was extended 534 
to 4 hours and performed with a mixture of RNase A (10 μg/mL) and 2 vol% of an RNase 535 
cocktail enzyme mix from Thermo (#AM2288). From variants surviving the third selection 536 
cycle, 12 clones were picked, sequenced, and produced in E. coli. After affinity purification and 537 
SEC, variant NC-4 was chosen for detailed analysis based on its yield, RNA packaging, minimal 538 
aggregation, and structural homogeneity. 539 
 540 
Production and purification of NC-1, NC-2, NC-3, NC-4, NC-4*, and Dλ-NC-4 541 
All NCs were produced in E. coli BL21(DE3)-gold cells. Two-liter Erlenmeyer flasks containing 542 
800 mL LB medium were inoculated with 8 mL overnight cultures and incubated at 37 °C and 543 
200 rpm until the OD600 reached 0.5–0.7. Protein production was induced by adding IPTG to a 544 
final concentration of 0.5 mM. Cells were cultured at 25 °C for 18 hours and then harvested by 545 
centrifugation at 6,000 g and 15 °C for 20 min. The cell pellet from one 800-mL culture was 546 
resuspended in 20 mL LB medium, transferred and split into two 50-mL Falcon tubes. The 547 
medium used for transfer was removed by centrifugation at 4,000 g and 15 °C for 10 min, 548 
decanted, and aliquots of the cell pellet were frozen in liquid nitrogen and stored at −20 °C until 549 
purification. For purification, a cell pellet corresponding to 400 mL of culture volume was 550 
resuspended in 20 mL lysis buffer (50 mM sodium phosphate buffer at pH 7.4) containing 20 551 
mM imidazole, and either 200 mM (NC-3), 500 mM (NC-1 and NC-2), or 1 M (NC-4, NC-4*, 552 
and Dλ-NC-4) NaCl. The lysis buffer was supplemented with lysozyme (1 mg/mL). The mixture 553 
was incubated at room temperature for 20 min on an orbital shaker. After lysis by sonication 554 




Hielscher Ultrasonics GmbH) and clearance by centrifugation at 8,500 g and 15 °C for 25 min, 556 
the supernatant was loaded onto 3 mL of Ni(II)-NTA agarose resin in a gravity flow column. 557 
After incubation for 10 min and washing with lysis buffer containing 20 mM imidazole, NCs 558 
were eluted with elution buffer (50 mM sodium phosphate buffer at pH 7.4, 500 mM imidazole) 559 
containing 200 (NC-3) or 500 mM (NC-1, NC-2, NC-4, NC-4*, and Dλ-NC-4) NaCl. The eluted 560 
fractions were concentrated and buffer-exchanged into storage buffer containing 200 mM (NC-3 561 
and NC-4) or 500 mM (NC-1 and NC-2) NaCl using Amicon Ultra-15 centrifugal filter units 562 
(100 kDa MWCO, Merck Millipore). Protein capsids were further purified by SEC at room 563 
temperature using a Superose 6 increase 10/300 GL column equilibrated in storage buffer 564 
containing 200 (NC-3, NC-4, NC-4*, and Dλ-NC-4) or 500 mM (NC-1, NC-2) NaCl. Purified 565 
fractions were pooled, concentrated, aliquoted, and either analyzed immediately, or frozen in 566 
liquid nitrogen and stored at –80 °C. Where stated, NC-4 was further purified by anion exchange 567 
chromatography at room temperature using a MonoQ 10/100 column (Pharmacia Biotech). The 568 
mobile phase consisted of storage buffer containing 200–1000 mM NaCl. 569 
For NC-3 and NC-4 variants, protein and RNA concentrations were measured by UV 570 
absorbance and deconvoluted using a previously reported protocol (36). For NC-1 and NC-2, this 571 
calculation could not be applied, likely because scattering from aggregating particles skewed 572 
absorbance values. Extinction coefficients for proteins were calculated using the ExPASy 573 
ProtParam tool (37). Wild-type AaLS was produced and purified as previously reported (38). 574 
 575 
Negative-stain transmission electron microscopy (TEM) 576 
Negative-stain TEM was performed as reported previously (39). Briefly, TEM grids (#01814-F, 577 
Ted Pella, Inc.) were negatively glow discharged at 15 mA for 45 s with a Pelco easiGlow Glow 578 
Discharge Cleaning System. After FPLC purification, grids were incubated with the capsid 579 
solution (10 μM monomer in storage buffer containing 200 mM NaCl) for 1 min, washed twice 580 
with doubly distilled water (ddH2O), and once with TEM staining solution (2% wt/vol aqueous 581 
uranyl acetate, pH 4), after which the grids were incubated with staining solution for 10 s, dried, 582 
and imaged using a TFS Morgagni 268 microscope. 583 
 584 
In vitro transcription of reference mRNAs 585 
Reference messenger RNAs (mRNAs) for real-time quantitative PCR (RT-qPCR) were prepared 586 
by runoff in vitro transcription. DNA templates were prepared by PCR with primer 5 (primer 5: 587 
5’- GCG AAA TTA ATA CGA CTC ACT ATA G) and primer 6 (primer 6: 5’- CAA AAA ACC 588 
CCT CAA GAC CC) from plasmids pMG-dB-NC-1 to pMG-dB-NC-4 using the LongAmp Taq 589 
assay (#M0287, NEB). PCR-amplified templates were gel-purified using the DNA Clean & 590 
Concentrator-5 kit. In vitro transcription reactions were performed using T7 RNA polymerase 591 
(#EP0111, Thermo Scientific) according to the manufacturer’s protocol. Template DNA was 592 
digested by RQ1 DNase and RNA was precipitated with isopropanol. RNA samples were 593 
purified twice by denaturing polyacrylamide electrophoresis (PAGE). Briefly, preparative urea 594 
PAGE gels (20 cm x 16 cm x 0.1 mm) were prepared in Tris/borate/EDTA (TBE) buffer 595 
supplemented with 8 M urea and 5% polyacrylamide. Polymerization was initiated using 596 
TEMED (8 μL per 10 mL gel solution) and APS (10% in water, 90 μL per 10 mL gel solution). 597 
RNA bands were visualized by UV shadowing and excised with a scalpel. The gel pieces were 598 
crushed with a pipet tip and the RNA was extracted in water containing 0.3 M NaCl overnight at 599 
room temperature. The next day, the RNA was purified by ethanol precipitation and dissolved in 600 




(for pure RNA, both ratios are ≥2.0) and by analytical PAGE gels. RNA concentrations were 602 
measured using the Qubit RNA HS assay (#Q32852, Invitrogen). 603 
 604 
Extraction of nucleocapsid RNA and RT-qPCR 605 
RNA was extracted from 100-µL or 200-µL aliquots of purified NCs containing a total amount 606 
of 5–10 µg RNA using the RNeasy Mini kit (#74104, QIAGEN) following the manufacturer’s 607 
instructions. RNA standards were prepared by in vitro transcription as described above. After 608 
ensuring that RNA samples were free of contaminants by absorbance, concentrations from 609 
extracted RNAs and in vitro-transcribed standards were measured with the Qubit RNA HS 610 
Assay. cDNA of the capsid’s genome was prepared by reverse transcription with primer 7 (5’- 611 
CCA AGG GGT TAT GCT AGT TAT TGC TCA GC) and SuperScript III reverse transcriptase 612 
(#18080044, Invitrogen) according to the manufacturer’s protocol. After the reverse transcription 613 
reaction, RNase H (#18021014, Invitrogen) was added to digest RNA transcripts. Immediately 614 
following the reverse transcription reaction, dilutions of the cDNA were mixed with KOD SYBR 615 
qPCR Master Mix (#QKD-201, TOYOBO), primers 8 (5’- TGT GAG CGG ATA ACA ATT 616 
CCC CTC) and 9 (5’- GGG TTA TGC TAG TTA TTG CTC AGC G), and ROX reference dye 617 
according to the manufacturer’s protocol. cDNA was amplified in 40 PCR cycles on a 618 
StepOnePlus thermocycler (Applied Biosystems) employing the thermocycler-specific PCR 619 
conditions provided in the qPCR mix manual. Absolute amounts of full-length genome were 620 
determined using standard curves prepared with cDNA originating from highly pure in vitro-621 
transribed reference RNAs. The full RT-qPCR experiments to quantify the fraction of full-length 622 
mRNA in the total isolated RNA were repeated in two separate laboratories (by Angela Steinauer 623 
at ETH Zurich and by Naohiro Terasaka at the University of Tokyo) to ensure reproducibility. 624 
 625 
Long read sequencing 626 
Nanopore sequencing was performed as described previously (6). Oxford Nanopore Technology 627 
relies on polyadenylated RNAs. Therefore, the extracted NC RNAs were polyadenylated using 628 
E. coli poly(A) polymerase (#M0276, NEB) and purified using the RNA Clean & Concentrator-5 629 
kit (#R1015, Zymo Research). cDNA libraries were prepared with the Direct cDNA Sequencing 630 
Kit (#SQK-DCS109, Oxford Nanopore Technologies) and Native Barcoding Kit 1D (#EXP-631 
NBD104, Oxford Nanopore Technologies) following the manufacturer’s protocols. Sequencing 632 
was carried out in a flow cell (#FLO-MIN106) using the 72-h 1D protocol. Base calling and de-633 
multiplexing were performed using Oxford Nanopore Technology’s Guppy Basecalling Software 634 
(version 3.2.10+aabd4ec). Adapter sequences of demultiplexed reads were removed using 635 
Porechop (version v0.2.4, https://github.com/rrwick/Porechop). Reads were mapped to the 636 
plasmid reference genome and to the E. coli genome (RefSeq: NC_000913.3) using Minimap2 637 
(version 2.17 (r941), https://github.com/lh3/minimap2). Index reference files containing the 638 
pMG plasmid genomes and the E. coli genome were prepared using samtools (version 1.10, 639 
https://github.com/samtools/). Index reference files and mapped reads were imported into CLC 640 
Genomics Workbench (version 12.0, QIAGEN Bioinformatics). Alignments were sorted and the 641 
read sequences and lengths corresponding to the most abundant gene classes were extracted 642 
using samtools. For each gene, we calculated the sum of all gene-specific base pairs and 643 







Nuclease challenge assay 648 
Aliquots of nucleocapsids containing a total amount of 5–10 µg RNA were treated in 50 mM 649 
sodium phosphate buffer at pH 7.4, 200 mM NaCl, 5 mM EDTA, 5 mM MgCl2 either lacking 650 
nuclease or supplemented with benzonase (2.5 U/μL; 101654, Merck Millipore) or RNase A 651 
(10 μg/mL; #R4875, Sigma-Aldrich). The concentration of RNA and protein was held constant 652 
at 80 ng RNA/μL, which corresponds to about ~5 μg protein/μL. Aliquots were challenged with 653 
the respective nucleases at 37 °C for the indicated time periods after which samples were frozen 654 
in liquid nitrogen and stored at –80 °C. For analysis, RNA was extracted from the capsid as 655 
previously described (5). A nuclease-treated NC solution (100 µL) was mixed with TRIzol 656 
(500 µL), vortexed for 3–5 s, and left on ice for 10 min. Then, chloroform (100 µL) was added, 657 
the samples were vortexed again, and the two phases were separated by centrifugation at 658 
15,000 g for 20 min. The upper, aqueous layer (~300 µL) was carefully transferred to a clean 659 
Eppendorf tube and mixed with an equal volume of 20% ethanol in nuclease-free water. This 660 
extraction step was essential to remove nuclease contamination. Subsequently, the solution was 661 
transferred to an RNeasy Mini spin column, and RNA purified according to the manufacturer’s 662 
protocol. 663 
RNA stability was visualized on denaturing PAGE gels. Analytical urea PAGE gels (8.3 cm x 664 
7.3 cm x 0.1 mm) were prepared in TBE buffer supplemented with 8 M urea and 8% 665 
polyacrylamide. Polymerization was initiated using TEMED (8 μL per 10 mL gel solution) and 666 
ammonium persulfate (APS) (10% in water, 90 μL per 10 mL gel solution). Gels were loaded 667 
with equal volumes of extracted RNA. The NC genome was selectively visualized using the 668 
fluorogenic dye DFHBI-1T (#446461, United States Biological), which fluoresces upon binding 669 
to the Broccoli aptamer that is part of the BoxBr tags (13). Total RNA was visualized using 670 
GelRed (#41002, Biotium). 671 
 672 
Cryo-electron microscopy: data collection and image processing 673 
Freshly purified NCs were concentrated in storage buffer. NC-1 and NC-2 eluted as two major 674 
peaks from the SEC column, both of which were pooled for analysis. These variants were 675 
concentrated to a 280-nm absorbance of 20–30, as the protein concentration could not be 676 
estimated accurately due to the high absorbance ratio of 260/280 nm mentioned above. NC-3 and 677 
NC-4 were concentrated to 4–5 mg/mL. Copper-supported holey carbon grids (R2/2 Cu 400, 678 
Quantifoil) were negatively glow discharged at 15 mA for 15 s with a Pelco easiGlow Glow 679 
Discharge Cleaning System. Then, 3.5 µL of sample were applied and blotted with a vitrobot 680 
(FEI) for 12 to 14 s at 25 blot strength, 100% humidity, and 22 °C. Grids were plunged into 681 
liquid ethane and stored in liquid nitrogen. 682 
Initial screening for all capsids and data collection for NC-3 were performed with a TFS 683 
Tecnai F20 equipped with a Falcon II direct electron detector (FEI). Movies of 7 frames were 684 
collected at a total dose of 40 electrons per Å2 and a magnification of 62,000x (1.8 Å pixel size). 685 
Defocus ranged from –1.8 to –3.3 µm. NC-1, NC-2, and NC-4 data collection was performed on 686 
a Titan Krios equipped with a Falcon III direct electron detector (FEI). Movies of 40 frames 687 
were collected at a dose of 60 electrons per Å2 and a magnification of 130,000x (1.1 Å pixel 688 
size). NC-4 was collected in electron counting, NC-1 and NC-2 in integration mode. Defocus 689 
ranged from –0.8 to –2.7 µm. 690 
All single-particle reconstructions were performed in Relion 3.0 (40). Motion correction was 691 
performed with MotionCor2 (41) implemented in Relion, contrast transfer function (CTF) 692 




manual inspection. For NC-1, NC-2, and NC-3, early classifications were performed with CTF 694 
ignored up to the first peak to avoid grouping into a few, featureless classes. 695 
Reconstruction of NC-1 and NC-2 structures was complicated by heterogeneity and 696 
aggregation. 2D classification was performed with multiple different mask sizes in order to 697 
obtain classes with distinct features for differently sized species. These classes were then used 698 
for the generation of initial 3D models of the tetrahedrally symmetric 120-mer (NC-1) and 180-699 
mers (NC-1 and NC-2). For the final reconstruction though, as shown in Figs. S5 and S6, 2D 700 
classification was performed with a single large mask and size differences mainly separated 701 
subsequently in 3D classification, as this procedure led to higher particle numbers and 702 
consequently better resolution. We tried to reconstruct additional 3D structures from the 703 
heterogenous particles, but no other reasonable models could be obtained. Single- or multi-704 
reference 3D classification based on known AaLS-derived structures, such as the 240-subunit 705 
capsid, or hollow spheres were not successful. The inability to extract further structures from the 706 
samples likely reflects substantial aggregation, low particle numbers of individual capsid 707 
architectures, shape irregularities, and lower symmetry. 708 
In contrast to NC-1 and NC-2 particles, NC-3 and NC-4, were better behaved and more 709 
homogeneous, making data elaboration according to standard procedures (40) fairly 710 
straightforward. Good 2D classes were used to generate initial models with imposed icosahedral 711 
symmetry. The best classes from 3D classification, masked around the capsid shells, were further 712 
refined. Further processing steps are described in Fig. S7. 713 
Model building and refinement were performed in Coot 0.8.9.2 (43), Phenix 1.18 (44), and 714 
Pymol 2.0. Electron density maps from 3D refinement, postprocessing in Relion, and 715 
autosharpening in Phenix were used during model building. NC-1, NC-2, and NC-4 models were 716 
based on a crystal structure of the wild-type lumazine synthase (PDB-ID: 1hqk). 717 
Atomic models were initially built into the asymmetric units and refined. After symmetry 718 
expansion, the full capsids were refined with non-crystallographic symmetry constraints to 719 
reflect the symmetry imposed during reconstruction. Experimental data versus model geometry 720 
were weighted in Phenix to optimize both electron density fit and geometry. While the core fold 721 
of the protomers in the tetrahedrally symmetric capsids were well resolved, the maps for the 722 
segment encompassing residues 66–81 displayed lower local resolution in subunits where this 723 
area is exposed towards the capsid openings and not in contact with neighboring protomers. 724 
These segments were built by repositioning the known structural elements of the wild-type 725 
protein as rigid groups and remodeling the flanking linkers according to visible density and 726 
chemical constraints, although multiple alternative conformations may exist. The pseudo-atomic 727 
NC-3 model is based on the structure of NC-4 with reversion of the mutations and an additional 728 
cycle of refinement to satisfy geometric and steric constraints. More information on data 729 
collection and model building is found in Table S1. 730 
 731 
XRF data collection and analysis 732 
XRF experiments were performed as described (26) and analyzed using QuShape (45) modified 733 
to incorporate sample replicate comparisons. In vitro-transcribed and NC-packaged RNAs were 734 
exposed in triplicate to X-ray pulses of 25 or 50 ms at the National Synchrotron Light Source II, 735 
beamline 17-BM XFP at Brookhaven National Laboratory (Upton, NY). Packaged RNA was 736 
subsequently extracted from the protein shell by standard techniques (26). 737 
Nucleotide modification propensity (reactivity) is directly related to residue mobility, and thus 738 




capillary electrophoresis sequencing using three dye-labeled primers (primer 10: 5’- CCA AGG 740 
GGT TAT GCT AGT TAT TGC TCA GC; primer 11: ATG CTA CGA TAC CGA AAC GAA 741 
GGC; primer 12: 5’- CTC GAT AGC CTG TTC CAA GGT G) that cover ~90% of the genome, 742 
including the coding region of the structural protein. Pairwise Pearson correlation coefficients 743 
(PCC) for normalized replicates gave best correlations overall at 50 ms exposure (Table S3), and 744 
the respective data were therefore further analyzed. XRF footprints showing normalized 745 
reactivities for each nucleotide were generated for both the free and packaged state using 746 
established protocols (27, 28). 747 
To find potential packaging signals (PSs), we looked for sequences similar to the UGxAxAA 748 
motif (x, any nucleotide) and the UGxA submotif, which are known to bind the lN+ peptide 749 
(25). Eighteen occurrences of URxRxRR (R, any purine) and 21 of URxRxxx were identified in 750 
the mRNA transcripts of both NC-3 and NC-4 (Table S2). Contact with the RNA-binding 751 
peptide would result in lowered reactivity. Of the 39 identified sites, only 13 (highlighted in grey 752 
in Table S2) displayed such low reactivity levels (green and black colored nts in Table S2), 753 
including the two copies of the BoxB sequence (BB1 & BB2). 754 
XRF reactivity levels were used as constraints to weight RNA secondary structure 755 
predictions. We used a modification of the RNA folding algorithm S-fold that includes such data 756 
via a scaling factor (m) and an offset (b) to generate a statistical sample of secondary structures 757 
from the Boltzmann ensemble of RNA secondary structures (27). Typically, the (m,b) 758 
combination that best represents a known secondary structure element within a probed RNA is 759 
identified, and that combination is used to predict the overall secondary structure (28). Because 760 
the reported stem-loop of the BoxBr tag contains C-G base pairs that stabilize the stem (12), it 761 
occurs with high probability in the ensembles for many (m,b) combinations, and it is therefore 762 
insufficiently discriminatory to identify a unique (m,b) combination. We therefore computed 763 
1000 statistical (Boltzmann-weighted) sample folds for all 1116 (m,b) combinations for m values 764 
between 0 and 7 and b values between 0 and -6, in increments of 0.2. Computing multiple folds 765 
per (m,b) combination takes into consideration that large RNAs occur as ensembles of secondary 766 
structures with comparable folding free energies. For any of the sites to act as packaging signals, 767 
they must be presented with sufficient frequency in the ensemble. In order to identify trends, the 768 
maximum, minimum and average frequency of stem-loops overlapping with the identified motifs 769 
were computed over all sample folds and all (m,b) combinations tested, both for the in vitro 770 
transcript and packaged RNA. Of the 13 identified sites, only seven (BB1, BB2, and PS1–5; 771 
Table S2) appear as part of a loop in either NC-3 or NC-4 with significant frequency (>50% of 772 
the folds in >50 of the (m,b) combinations). 773 
For the calculation of representative folds of the packaged NC-3 and NC-4 mRNA, (m,b) 774 
values were chosen taking into account contributions from all PSs which were preferentially 775 
displayed in the packaged over free transcripts via their cumulative normalized frequencies of 776 
occurrence (Figs. S12,S13). Two local probability maxima were identified for both packaged 777 
mRNAs, and structures computed for both. Maximum ladder distances for these folds (Figs. 778 
S12,S13) show that evolution did not select for genome compactness, likely because the mRNA 779 
is considerably smaller than the packaging capacity of the evolved T=4 capsids. 780 





Fig. S1. Nucleocapsid design and evolution. 783 
(A) NC-1 was generated by circular permutation of AaLS and addition of the λN+ peptide to the new N-784 
terminus (6). Directed evolution over three generations with increasingly stringent nuclease challenge in 785 
each step yielded NC-4. As explained in the Materials and Methods section, the previously described 786 
nucleocapsids were renamed to clarify their evolutionary relationships. (B) Size-exclusion 787 
chromatograms of purified, re-injected nucleocapsids (column: Superose 6 increase 10/300 GL). (C) 788 
Transmission electron micrographs of purified capsids. Scale bar: 50 nm. (D) Capsid stability towards 789 
nucleases: Purified NCs were incubated without nuclease (–), or treated with benzonase (+b), or RNase A 790 
(+R) for 1 hour at 37 °C. RNA was extracted and equal volumes were loaded onto a denaturing PAGE 791 
(8%) gel. Total RNA was stained with GelRed, nucleocapsid mRNA (NC RNA) was visualized with 792 
DFHBI-1T, a small molecule that fluoresces upon binding to the broccoli aptamer present in the 5’- and 793 
3’-untranslated regions of the capsid mRNA. IVT = in vitro-transcribed reference mRNA. The dashed 794 
line indicates two non-concurrent portions of the same gel image. (E) Purified NC-4 was treated with 795 





Fig. S2. Sequence alignment of NC-1 to NC-4. 798 
(A) mRNA and (B) protein sequences of NC-1 to NC-4 (green = BoxBr tags, magenta = λN+ peptide, 799 
blue = (GlyAla)-linker, yellow = cpAaLS).  800 





Fig. S3. Fourth generation nucleocapsids. 803 
Protein sequences of the nucleocapsids that were isolated in the final round of selection are shown. X 804 
indicates sequencing ambiguity; for NC-4_11, sequencing failed. As noted in the text, NC-4 yielded 805 
homogeneous, well-behaved particles and was selected for detailed characterization. Like all the variants, 806 
it contains mutations in the N-terminal lN+ peptide and in the external loop introduced by circular 807 
permutation, which may influence RNA binding affinity and capsid assembly/stability, respectively.  808 
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Fig. S4. RNA cargo identified by long-read sequencing. 810 
(A) Pie chart representations of main gene classes identified by nanopore sequencing (34). (B) Relative 811 
fraction of identified gene classes in percent calculated by adding gene-specific base pairs (bps) and 812 
comparing them to the sum of all recorded bps. (C and D) UGxAxAA (red) and URxRxRR (orange) 813 
motifs are mapped onto the 50S (C) and 30S (D) subunits of the E. coli ribosome (PDB: 5h5u). The 23S 814 
rRNA is colored in dark blue, the 16S rRNA in light blue, accessory proteins are shown as cartoons. The 815 
ubiquity and compactness of ribosomes, together with interactions between some of the exposed BoxB-816 







Fig. S5. Single particle reconstruction of NC-1 structures. 821 
(A) 1,053 movies were analyzed for reconstruction of NC-1 (scale bar: 50 nm). (B) From these, 129,954 822 
particles were picked and classified in 2D. (C) Size differences of the heterogeneous particles were 823 
initially classified in 3D with multiple references and lower symmetry (C1 and C3). References included 824 
the NC-4 structure (Fig. S7). (D and G), Particles were further classified with tetrahedral symmetry, using 825 
initial models generated beforehand by 2D classification with tight masks and then imposition of 826 
tetrahedral symmetry on classes showing distinct features. As indicated, further 2/3D classifications of 827 
classes highlighted in yellow, polishing, and refinement with imposed tetrahedral symmetry led to the 828 
final structures. (E and H) Refined maps, colored by local resolution, of the 180-mer (5,226 particles, 829 
4.20 Å) (E) and the 120-mer (5,257 particles, 3.50 Å) (H). (F and I), Gold-standard Fourier-shell 830 





Fig. S6. Single particle reconstruction of NC-2. 833 
(A) 509 movies were used to analyze NC-2 (scale bar: 50 nm). (B) 29,998 particles were classified in 2D. 834 
(C) Non-junk particles were further classified in 3D with multiple references (including the structure of 835 
NC-4, Fig. S7) with C3-symmetry. (D) Further 3D classification (with tetrahedral symmetry) of classes 836 
highlighted in yellow, contrast transfer function (CTF) refinement, polishing, and refinement with 837 
tetrahedral symmetry of individual classes led to the final structures. (E) Refined map, colored by local 838 






Fig. S7. Single particle reconstruction of NC-3 (A–E) and NC-4 (F–J). 842 
(A and F) Sample movies from NC-3 (A) and NC-4 (F) micrographs (scale bar: 50 nm). (B and G) 843 
Particles were classified in 2D, and symmetric classes with clear features processed further. (C and H) 844 
Initial model generation and 3D classification were performed with imposition of icosahedral symmetry. 845 
For NC-4, multiple highly similar 3D classes (highlighted in yellow) were pooled. Particles were further 846 
processed as indicated. (D) Postprocessed map of NC-3 (3,815 particles, 7.0 Å). (I) Refined map of NC-4 847 






Figure S8: Architectural adaptation from T=1 to T=4. 851 
(A) AaLS (EMDB:3538) is shown with pentamers highlighted in shades of grey, and three symmetric 852 
monomers highlighted in red, green and yellow. (B) Representation of the capsid in panel A on a gyrated 853 
hexagonal lattice (46). (C) Three C3-symmetric AaLS monomers outlined by black (C) or white (A and 854 
B) solid lines barely interact in the wildtype fold. (D) NC-4 structure. A trimer composed of quasi-855 
symmetric monomers is highlighted in red, green, and yellow in NC-4. (E) A lattice representation of 856 
NC-4 shows that its intricate architecture is still based on the same gyrated hexagonal lattice as AaLS. 857 
Differences arise due to the domain swap and the addition of the external loop introduced by circular 858 
permutation. (F) Three quasi-symmetric monomers, outlined by black (F) or white (D and E) lines, 859 
interact closely after the domain swap. (G) An overlay of the two different sets of trimers (Fig. 3B) 860 
composing NC-4 further highlights the quasi-equivalence between chains that compose the 240-mer. The 861 
“blue” trimer has a slightly more acute hinge angle than the red/green/yellow trimers, which allows it to 862 





Figure S9: Mutations from NC-1 to NC-4 865 
(A) Subunits of NC-1, NC-2, and NC-4 are shown with mutations indicated as spheres and color coded 866 
according to their order of appearance (NC-2, white; NC-3, light blue; NC-4, dark blue). (B) Surface 867 
representation of a pentamer excised from the NC-4 structure shown in Fig. 2, which comprises the N-868 
terminal fragments of the yellow subunits (residues 1–74) and the C-terminal fragments of the red 869 
subunits (76–197). Because the penton-hexon interfaces contain relatively few mutations, the original 870 
AaLS interfaces are largely preserved upon expansion from a T=1 to a T=4 structure. (C) Surface 871 
representation of an NC-4 trimer. The mutations introduced into NC-2 (white) are located at the interfaces 872 
between the domain-swapped subunits, whereas subsequent mutations (light and dark blue) are located 873 
mainly on the interior and exterior capsid surfaces and the inter-trimer interfaces. (D) The G177D 874 
mutation, which first appeared in NC-3, may stabilize trimer-trimer interactions in the expanded 875 
structures. The aspartate side chain inserts into a network of charged residues and likely forms a salt 876 





Fig. S10. Reversion of the K5R mutation in NC-4. 879 
(A) Size-exclusion chromatograms of purified, re-injected nucleocapsid (column: Superose 6 increase 880 
10/300 GL). (B) Transmission electron micrograph of purified R5K NC-4 (NC-4*). Scale bar: 50 nm. (C) 881 
RNA was extracted from each nucleocapsid generation and equal amounts were loaded onto a denaturing 882 
PAGE (5%) gel. Total RNA was stained with GelRed, NC RNA was visualized with DFHBI-1T. The 883 
DFHBI-1T-stained gel on the right was overexposed to better visualize faint bands. The dashed line 884 
indicates two non-concurrent portions of the same gel image. 885 





Fig. S11. Removal of the RNA-binding motif in NC-4. 888 
(A) Size-exclusion chromatograms of purified, re-injected NC-4 capsid lacking the λN+ peptide and the 889 
(GlyAla)-linker (residues 1–30; Dλ-NC-4) (column: Superose 6 increase 10/300 GL). (B) Transmission 890 
electron micrograph of purified Dλ-NC-4. Scale bar: 50 nm. 891 
 892 
 893 





Fig. S12. Secondary structure prediction based on XRF data for NC-3. 896 
(A) The minimum, maximum and average number of times a given SL occurs in an ensemble of 1000 897 
sample folds, generated using a modified version of the S-fold algorithm that includes the XRF data via a 898 
scaling factor m and an offset b, was computed for each of 1116 (m,b) combinations (see panel B). The 899 
seven potential packaging signals listed occur in at least 50% of the 1000 sample folds for at least 50 of 900 
the 1116 (m,b) combinations. Stem-loops for which the average number increases for packaged mRNA 901 
compared with the free transcript, or vice versa, are highlighted; if the lower value is within 85%, it is 902 
highlighted in lighter shade. (B) Stem-loops with entries highlighted in packaged RNA in A are 903 
collectively optimized via a cost function given by the sum of the normalized (by their maximal number 904 
of occurrence) frequencies for these SLs in an ensemble of 1000 sample folds for each (m,b) combination. 905 
This identifies (m,b) values for which their occurrence is locally maximally aligned with the trend in the 906 
tables in A. The (m,b) combinations for which the cost function is maximal are:  m=1.6, b=-2.4 (77.6%, 907 
labelled 1) and m=2.2, b=-1.4 (75.7%, labelled 2). (C) The predicted folds corresponding to these (m,b) 908 
combinations, represented as cartoons in Figure 4C, are shown with their full sequence. The maximum 909 
ladder distances are 98 for fold (1), and 102 for fold (2). 910 
  911 
Transcript Packaged
Max Min Avg Max Min Avg
PS1 1000 0 120 1000 0 578
BB1 1000 90 963 1000 0 628
PS2 922 0 37 1000 0 526
PS3 687 0 41 981 0 135
PS4 1000 2 679 1000 2 867
PS5 721 0 209 729 0 216
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Fig. S13. Secondary structure prediction based on XRF data for NC-4. 913 
(A) The minimum, maximum and average number of times a given SL occurs in an ensemble of 1000 914 
sample folds, generated using a modified version of the S-fold algorithm that includes the XRF data via a 915 
scaling factor m and an offset b, was computed for each of 1116 (m,b) combinations (see panel B). The 916 
seven potential packaging signals listed occur in at least 50% of the 1000 sample folds for at least 50 of 917 
the 1116 (m,b) combinations. Stem-loops for which the average number increases for packaged mRNA 918 
compared with free transcript, or vice versa, are highlighted; if the lower value is within 85%, it is 919 
highlighted in lighter shade. (B) Stem-loops with entries highlighted in packaged RNA in A are 920 
collectively optimized via a cost function given by the sum of the normalized (by their maximal number 921 
of occurrence) frequencies for these SLs in an ensemble of 1000 sample folds for each (m,b) combination. 922 
This identifies (m,b) values for which their occurrence is locally maximally aligned with the trend in the 923 
tables in (A). The (m,b) combinations for which the cost function is maximal are: m=4.6, b=-2.6 (79.9%, 924 
labelled 1) and m=2.6, b=-3.0 (79.0%, labelled 2). (C) The predicted folds corresponding to these (m,b) 925 
combinations, represented as cartoons in Figure 4D, are shown with their full sequence. The maximum 926 
ladder distances are 125 for fold (1), and 105 for fold (2). 927 
 928 
  929 
260
Transcript Packaged
Max Min Avg Max Min Avg
PS1 429 0 16 1000 0 460
BB1 1000 11 914 1000 794 990
PS2 900 0 80 1000 0 376
PS3 585 0 31 605 0 58
PS4 1000 1 691 1000 0 609
PS5 731 0 334 697 0 82

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table S1. Cryo-EM data  931 
NC-1 120-mer NC-1 180-mer NC-2 NC-3 NC-4
EMDB map entry 11631 11632 11633 11634 11635
PDB coordinate entry 7A4F 7A4G 7A4H 7A4I 7A4J
Data Collection and reconstruction
Microscope model FEI Titan Krios FEI Titan Krios FEI Titan Krios FEI Tecnai F20 FEI Titan Krios
Detector model Falcon III Falcon III Falcon III Falcon II Falcon III
# of Micrographs collected 1481 1481 848 134 1080
Magnification 130 000x 130 000x 130 000x 62 000x 130 000x
Voltage (kV) 300 300 300 200 300
Electron dose (e-/A2) 60 60 60 40 60
Pixel Size (Å) 1.1 1.1 1.1 1.8 1.1
Defocus range (µm) -0.8 to -2.6 -0.8 to -2.6 -0.8 to -2.6 -1.8 to -3.3 -0.8 to -2.6
Symmetry imposed T T T I1 I1
# of Micrographs used 1 053 1 053 509 111 1 067
Initial particle images 129 954 129 954 29 998 32 411 69 723
Final particle images 5 257 5 226 4 037 3815 15 392
Resolution (Å) (at FSC = 0.143 3.50 4.20 4.47 7.04 3.04
Map sharpening B-factor (Å2) -31 -52 -141 -550 -66
Model building
Starting model 1hqk 1hqk 1hqk 7a4j 1hqk
Composition
  Chains 120 180 180 240 240
  Atoms 141432 205680 204396 290520 289560
  Protein residues 18540 27120 26904 37860 37860
  Water 0 0 0 0 0
  Ligands 0 0 0 0 0
Bonds (RMSD) 
  Length (Å) (# > 4σ)  0.002 (0) 0.002 (0) 0.002 (0) 0.002 (0) 0.002 (0)
  Angles (°) (# > 4σ) 0.430 (12) 0.383 (34) 0.396 (0) 0.466 (189) 0.402 (0)
MolProbity score 1.83 1.46 1.67 1.86 1.58
Clash score 6.30 6.41 6.06 5.65 3.77
Ramachandran plot (%)
  Outliers 0 0 0 0 0
  Allowed 2.36 2.27 1.81 2.57 1.82
  Favored 97.64 97.73 98.19 97.43 98.18
Ramachandran plot Z-score
  whole 1.60 (0.06) 2.89 (0.06) 3.99 (0.05) 1.36 (0.04) 0.40 (0.04)
  helix 2.31 (0.05) 2.64 (0.05) 3.81 (0.04) 2.05 (0.04) 1.02 (0.04)
  sheet 0.45 (0.08) 1.44 (0.07) 2.32 (0.07) 1.59 (0.07) 1.39 (0.07)
  loop 0.02 (0.10) 0.95 (0.09) 0.73 (0.08) 1.04 (0.05) 1.28 (0.05)
Rotamer outliers (%)  3.40 1.14 2.76 3.80 3.50
Cβ outliers (%)  0 0 0 0 0
Peptide plane (%) 
  Cis proline/general 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
  Twisted proline/general 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
CaBLAM outliers (%) 0.07 0.93 1.1 1.14 0.98
ADP (B-factors)  
  Iso/Aniso (#) 141432/0 205680/0 204396/0 290520/0 289560/0
  min/max/mean  45.97/167.52/91.60 14.53/153.78/58.76 34.68/253.39/95.22 96.48/410.28/208.34 41.87/138.99/82.97
Occupancy   
  Mean  1 1 1 1 1
  occ = 1 (%) 100 100 100 100 100
Box                                                                                         
  Lengths (Å)                    248.88, 250.25, 250.25 301.12, 301.12, 303.88 303.88, 302.50, 301.12 333.00, 333.00, 333.00 324.50, 324.50, 324.5
  Angles (°)                      90.00, 90.00, 90.00 90.00, 90.00, 90.00 90.00, 90.00, 90.00 90.00, 90.00, 90.00 90.00, 90.00, 90.00
Model vs. Data
  CC (mask) 0.84 0.78 0.73 0.8 0.81
  CC (box)                                0.78 0.72 0.69 0.82 0.69
  CC (peaks)                              0.72 0.65 0.58 0.69 0.64
  CC (volume)                              0.83 0.75 0.72 0.8 0.8








Position NC-3 NC-4   Position NC-3 NC-4  
32 UAGAGGG UAGAGGG PS1 
 
79 UAGAGUG UAGAGUG 
60 UGAAGAA UGAAGAA BB1 
 
84 UGUGGGC UGUGGGC PS2 
116 UAAGAAG UAAGAAG 
  
86 UGGGCUC UGGGCUC 
 
133 UAUGGGA UAUGGGA 
  
127 UAUACAU UAUACAU 
 
135 UGGGAAA UGGGAAA PS3 
 
129 UACAUAU UACAUAU 
 
172 UGAGAAA UGAGAAA PS4 
 
205 UGGAGCU UGGAGCU 
 
188 UGGAAAG UGGAAAG 
  
211 UGGAGCA UGGAGCA 
 
294 UACGCAA UACGUAA 
  
220 UGCAAUG UGCAAUG 
 
383 UGGGAAG UGGGAAG PS5 
 
245 UAUAACG UAUAACG 
 
420 UAUACAA UAUACAA 
  
256 UGUAGUU UGUAGUU 
 
482 UACGAAG UACGAAG 
  
288 UAGAACU UAGAACU 
 
564 UGGAGGG UGGAGGG 
  
298 CAAACCU UAAACCU 
 
581 UGCAUAG UGCAUAG 
  
322 UACAGCU UACAGCU 
 
604 UGAAGAA UGGAGAA 
  
336 UGGAACA UGGAACA 
 
641 UGGGAAA UGGGAAA 
  
406 UGAAAUG UGAAAUG 
 
676 UAAAGAG UAAAGAG 
  
422 UACAAGU UACAAGU 
 
734 UAAGCGG UAAGCGG 474 UUGAAAUC UUGAAAUC 
768 UGAAGAA UGAAGAA BB2 
 
490 UAAACUA UAAACUA 
 
     
631 UCCAGGC UCCAGGC 
 
     
658 UGCGGAU UGCGGAU 
 
664 UGAACUG UGAACUG 
Table S2. BoxB-like sequence motifs within the NC-3 and NC-4 genomes. 932 
Genome positions of nucleotide strings fulfilling the search motif together with the color-coded 933 
reactivities (black, green, orange and red from low to high) in NC-3 and NC-4. The 13 sequences that 934 
show sufficiently low reactivity to potentially act as packaging signals are highlighted in grey. Of these, 935 
seven motifs occur in a stem loop in over half of the sample folds for at least 50 m,b combinations tested. 936 
Two are the BoxBr tags (BB1, BB2), introduced by design, and the other five potential packaging signals 937 
are designated PS1-PS5 in the order they appear in the sequence. 938 







 Transcript   In situ 
  Transcript   
In situ 
Primer A B 
 
 A B 
 
 A B 
 
 A B 
12 
0.964   
 
B 0.718   
 
B 0.927   
 
B 0.899   
0.940 0.930 
 
C 0.774 0.869 
 
C 0.963 0.950 
 
C 0.893 0.976 
               
 A B 
 
 A B 
 
 A B 
 
 A B 
11 
0.932   
 
B 0.919   
 
B 0.931   
 
B 0.975   
0.919 0.981 
 
C 0.983 0.917 
 
C 0.715 0.725 
 
C 0.949 0.954 
               
 A B 
 
 A B 
 
 A B 
 
 A B 
10 
0.866   
 
B 0.865   
 
B 0.954   
 
B 0.952   
0.893 0.951 
 
C 0.927 0.918 
 
C 0.841 0.768 
 
C 0.957 0.954 
Table S3. Pairwise Pearson correlation coefficients (PCCs) for normalized replicates at 50 940 
ms exposure. 941 
PCCs for triplicate primer extensions, analyzed by primer region and RNA. A, B, and C represent the 942 
individual replicates. Lower values imply greater variability in the respective mRNA segment. 943 
